Hinge Health, Inc.
NYSE:HNGEMedical - Healthcare Information Services
-$0.24 today
- Market cap
- $9.31B
- Beta
- 1.99
- P/E (TTM)
- -10.3
- EPS (TTM)
- -$6.49
Volume 1.23M
Average 1.34M
HNGE Deferred Revenue
Payments received for goods or services the company will deliver within the next year.
Hinge Health, Inc.NYSE: HNGE
Deferred Revenue · Q2 FY2026 · quarter ended Jun 2026
Deferred revenue rises 51.4% from a year ago
Deferred revenue stood at $416.47M at the end of Q2 FY2026, up 51.4% from a year earlier and up 22.2% from the prior quarter.
Context
- Deferred revenue amounted to 50.3% of total assets at the end of Q2 FY2026, up 10.7 pp from a year earlier.
- Deferred revenue increased in 2 of the last 2 fiscal years.
- FY2025 was the highest annual figure in the 3 fiscal years shown.
What to watch
Whether deferred revenue keeps rising in the next quarterly balance sheet after a +51.4% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Deferred Revenue history
USD · from the balance sheet
- Latest · FY2025
- 300.86M USD
- Year-over-year change
- +38.2%
- 2-year CAGR
- +46.3%
| Period | Period end | Deferred Revenue | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 300.86M | +38.2% |
| FY2024 | 2024-12-31 | 217.63M | +54.9% |
| FY2023 | 2023-12-31 | 140.47M | — |
Deferred Revenue vs competitors
How HNGE compares with its peers on the latest reported figures
- HNGE's Jun 2026 deferred revenue of $416.47M is the highest of the 5 companies compared; the peer median is $3.56M.
- Its year-over-year change of +51.4% is the highest of 3, against a peer median of +16.2%.
- Deferred revenue amounts to 50.3% of total assets for HNGE, versus a peer median of 0.1%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Jun 2026 | $416.47M | +51.4% | — | 50.3% | |
| Mar 2026 | $29.35M | +28.8% | +23.1% | 9.7% | |
| Apr 2026 | $6.08M | +3.6% | +22.2% | 0.2% | |
| Mar 2026 | $1.03M | — | — | 0.1% | |
| Dec 2025 | $0 | — | — | 0.0% | |
| Peer median (excluding HNGE) | $3.56M | +16.2% | +22.6% | 0.1% | |
Competitors are the stored peer set for HNGE. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Hinge Health, Inc.
NYSE:HNGE
Intrinsic Alpha fair value
Locked
Current Price
$114.53
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.